Citation: D. El Wilcken et L. Brattstrom, Mild hyperhomocysteinemia: vitamin supplementation or not? Reply to R Cerone et al, AM J CLIN N, 74(2), 2001, pp. 271-272
Citation: L. Brattstrom et D. El Wilcken, Hyperhomocysteinemia and cardiovascular disease - Reply to K de Meer et al, AM J CLIN N, 73(5), 2001, pp. 993-993
Authors:
Cheng, Q
Jiang, GX
Press, R
Andersson, M
Ekstedt, B
Vrethem, M
Liedholm, LJ
Lindsten, H
Brattstrom, L
Fredrikson, S
Link, H
de Pedro-Cuesta, J
Citation: Q. Cheng et al., Clinical epidemiology of Guillain-Barre syndrome in adults in Sweden 1996-97: a prospective study, EUR J NEUR, 7(6), 2000, pp. 685-692
Authors:
Mudd, SH
Finkelstein, JD
Refsum, H
Ueland, PM
Malinow, MR
Lentz, SR
Jacobsen, DW
Brattstrom, L
Wilcken, B
Wilcken, DEL
Blom, HJ
Stabler, SP
Allen, RH
Selhub, J
Rosenberg, IH
Citation: Sh. Mudd et al., Homocysteine and its disulfide derivatives - A suggested consensus terminology, ART THROM V, 20(7), 2000, pp. 1704-1706
Authors:
Nielsen, NE
Brattstrom, L
Hultberg, B
Landgren, F
Swahn, E
Citation: Ne. Nielsen et al., Plasma total homocysteine levels in postmenopausal women with unstable coronary artery disease, ATHEROSCLER, 151(2), 2000, pp. 423-431
Authors:
Brattstrom, L
Brudin, L
Wilcken, DEL
Ohrvik, J
Citation: L. Brattstrom et al., Methylenetetrahydrofolate reductase gene and coronary artery disease - Response, CIRCULATION, 101(16), 2000, pp. E172-E173
Authors:
Wollesen, F
Brattstrom, L
Refsum, H
Ueland, PM
Berglund, L
Berne, C
Citation: F. Wollesen et al., Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus, KIDNEY INT, 55(3), 1999, pp. 1028-1035
Authors:
Brattstrom, L
Wilcken, DEL
Ohrvik, J
Brudin, L
Citation: L. Brattstrom et al., Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease - The result of a meta-analysis, CIRCULATION, 98(23), 1998, pp. 2520-2526